Your browser doesn't support javascript.
loading
Antithrombotic therapy in atrial fibrillation associated with valvular heart disease: a joint consensus document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology Working Group on Thrombosis, endorsed by the ESC Working Group on Valvular Heart Disease, Cardiac Arrhythmia Society of Southern Africa (CASSA), Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), South African Heart (SA Heart) Association and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLEACE).
Lip, Gregory Y H; Collet, Jean Philippe; Caterina, Raffaele de; Fauchier, Laurent; Lane, Deirdre A; Larsen, Torben B; Marin, Francisco; Morais, Joao; Narasimhan, Calambur; Olshansky, Brian; Pierard, Luc; Potpara, Tatjana; Sarrafzadegan, Nizal; Sliwa, Karen; Varela, Gonzalo; Vilahur, Gemma; Weiss, Thomas; Boriani, Giuseppe; Rocca, Bianca.
Afiliação
  • Lip GYH; Institute of Cardiovascular Sciences, University of Birmingham and Aalborg Thrombosis Research Unit, Department of Clinical Medicine, Aalborg University, Denmark.
  • Collet JP; Sorbonne Université Paris 6, ACTION Study Group, Institut De Cardiologie, Groupe Hôpital Pitié-Salpetrière (APHP), INSERM UMRS 1166, Paris, France.
  • Caterina R; Institute of Cardiology, 'G. D'Annunzio' University, Chieti, Italy.
  • Fauchier L; Centre Hospitalier Universitaire Trousseau et Faculté de Medicinde, Université François Rabelais, Tours, France.
  • Lane DA; Institute of Cardiovascular Sciences, University of Birmingham, United Kingdom; and Aalborg Thrombosis Research Unit, Department of Clinical Medicine, Aalborg University, Aalborg, Denmark.
  • Larsen TB; Thrombosis Research Unit,Department of Clinical Medicine, Aalborg University Hospital, Aalborg, Denmark.
  • Marin F; Hospital Universitario Virgen de la Arrixaca, Murcia, Spain.
  • Morais J; Department of Cardiology, Leiria Hospital Centre, Leiria, Portugal.
  • Narasimhan C; Department of Cardiac Electrophysiology, Care Hospital, Hyderabad, India.
  • Olshansky B; Mercy Hospital, Mason City, Iowa, USA.
  • Pierard L; Department of Cardiology, University Hospital Sart-Tilman, Liege, Belgium.
  • Potpara T; School of Medicine, Belgrade University; Cardiology Clinic, Clinical Center of Serbia, Belgrade, Serbia.
  • Sarrafzadegan N; Isfahan Cardiovascular Research Center (WHO Collaborating Center), Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran and School of Population and Public Health, University of British Columbia, Vancouver, Canada.
  • Sliwa K; Hatter Institute for Cardiovascular Research in Africa, Faculty of Health Sciences, University of Cape Town, South Africa; and Mary McKillop Institute, ACU, Melbourne, Australia.
  • Varela G; Servicio de Electrofisiología, Centro Cardiovascular Casa de Galicia, Hidalgos, Uruguay.
  • Vilahur G; Cardiovascular Science Institute - ICCC, IIB-Sant Pau, CiberCV, Hospital de Sant Pau, Barcelona, Spain.
  • Weiss T; Medical Department For Cardiology and Intensive Care, Wilhelminenhospital, and Medical Faculty Sigmund Freud University, Vienna, Austria.
  • Boriani G; Cardiology Department, University of Modena and Reggio Emilia, Policlinico di Modena, Modena, Italy.
  • Rocca B; Institute of Pharmacology, Catholic University School of Medicine, Rome, Italy.
Europace ; 19(11): 1757-1758, 2017 Nov 01.
Article em En | MEDLINE | ID: mdl-29096024

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fibrilação Atrial / Tromboembolia / Próteses Valvulares Cardíacas / Implante de Prótese de Valva Cardíaca / Acidente Vascular Cerebral / Fibrinolíticos / Doenças das Valvas Cardíacas Tipo de estudo: Clinical_trials / Diagnostic_studies / Etiology_studies / Guideline / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fibrilação Atrial / Tromboembolia / Próteses Valvulares Cardíacas / Implante de Prótese de Valva Cardíaca / Acidente Vascular Cerebral / Fibrinolíticos / Doenças das Valvas Cardíacas Tipo de estudo: Clinical_trials / Diagnostic_studies / Etiology_studies / Guideline / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2017 Tipo de documento: Article